By: IPP Bureau
Last updated : February 06, 2024 7:17 am
Sun Pharma Advanced Research Company has reported total income of Rs. 20.25 crores during the period ended December 31, 2023
Sun Pharma Advanced Research Company Limited has reported standalone financial results for the period ended December 31, 2023.
Sun Pharma Advanced Research Company has posted net loss of Rs. 99.65 crores for the period ended December 31, 2023 as against net loss of Rs. 86.42 crores for the period ended September 30, 2023. The company posted net profit of Rs.10.15 crores for the period ended December 31, 2022.
Sun Pharma Advanced Research Company has reported total income of Rs. 20.25 crores during the period ended December 31, 2023 as compared to Rs. 29.67 crores during the period ended September 30, 2023. The company reported total income of Rs.131.12 crores during the period ended December 31, 2022.
For the 9 months period ended December 31, 2023, Sun Pharma Advanced Research Company has reported total income of Rs.84.06 crores as compared to Rs.191.24 crores during the 9 Months period ended December 31, 2022.
The company has posted net loss of Rs.281.42 crores for the 9 months period ended December 31, 2023 as against net loss of Rs.140.59 crores for the 9 months period ended December 31, 2022.